Advances in the management of endometriosis: an update for clinicians
The DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.
Abstract
Endometriosis is a chronic and recurrent disease characterized by the presence and proliferation of endometrial tissue outside the uterine cavity, which occurs in approximately 10% of women of reproductive age. In this estrogen-dependent disorder, lesions become inactive and gradually undergo regression during states of ovarian down-regulation, such as amenorrhoea or menopause. The impact of endometriosis includes impaired fertility potential, as well as symptoms of dysmenorrhoea, dyspareunia and chronic non-menstrual pain, all of which adversely affect quality of life. Management of endometriosis focuses on pain relief and includes medical and surgical treatment. Pharmacologic therapies currently in use include combination oral contraceptives (COCs), danazol, GnRH analogues and progestins. Although some agents show efficacy in relieving pain, all differ in their side effects, making it difficult to achieve a balance between efficacy and safety. Efficacy has been demonstrated with danazol or GnRH analogues; however, treatment is limited to 6 months because of significant metabolic side effects. Alternatives for longer-term management of symptoms include add-back therapy with GnRH analogues, COCs or progestins. Newer options for treatment of endometriosis include depot medroxyprogesterone acetate subcutaneous injection, as well as several agents under investigation that may prove to have therapeutic potential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Levonorgestrel (LNG) has also been used for treating women with symptomatic minimal-to-moderate endometriosis [10], leading to improvements in the severity and frequency of pain and menstrual symptoms.”
From Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment (2012) · cites this paper as [10]
Citations
Cites
Eskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
ESHRE guideline for the diagnosis and treatment of endometriosis
Kennedy, S., Bergqvist, A., Chapron, C., D’Hooghe, T., Dunselman, G., Greb, R., Hummelshoj, L., Prentice, A., & Saridogan, E. (2005) · Human Reproduction · doi:10.1093/humrep/dei135 · Cited by 1,584 · cited 1×
“…can be difficult, given the non-specific nature of many of its symptoms, the common occurrence of pelvic pain in women without endometriosis and the considerable overlap with other conditions (e.g. pelvic inflammatory disease or irritable bowel syndrome) (Child et al., 2001; Kennedy et al., 2005).”
BackgroundSelf-citationSelective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
Riggs, B. L., & Hartmann, L. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022219 · Cited by 968
Effect of endometriosis on in vitro fertilization
Barnhart, K., Dunsmoor-Su, R., & Coutifaris, C. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03112-6 · Cited by 794
Laparoscopic excision of endometriosis: A randomized, placebo-controlled trial
Abbott, J., Hawe, J., Hunter, D., Holmes, M., Finn, P., & Garry, R. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.046 · Cited by 502 · cited 5×
“Nevertheless, surgery is an invasive therapeutic option that is far from ideal, because 20% of cases do not respond (Abbott et al., 2004), and the recurrence rate is high after surgery (Milingos et al.”
BackgroundInfluentialPeritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis
Gazvani, R., & Templeton, A. (2002) · Reproduction · doi:10.1530/rep.0.1230217 · Cited by 394
Endometriosis and Subfertility: Is the Relationship Resolved?
(2003) · Seminars in Reproductive Medicine · doi:10.1055/s-2003-41330 · Cited by 321
Use and misuse of oral contraceptives: Risk indicators for poor pill taking and discontinuation
Rosenberg, M. J., Waugh, M. S., & Meehan, T. E. (1995) · Contraception · doi:10.1016/0010-7824(95)00074-k · Cited by 317
Vercellini, P., Trespidi, L., Colombo, A., Vendola, N., Marchini, M., & Crosignani, P. G. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56039-7 · Cited by 311 · cited 1×
“One small, open-label, randomized clinical study comparing goserelin with a cyclic low-dose COC containing ethinyl estradiol and desogestrel found a greater reduction in dyspareunia in the GnRH-analogue group and similar relief of nonmenstrual pain in both groups (Vercellini et al., 1993).”
BackgroundSelf-citationZieman, M., Guillebaud, J., Weisberg, E., Shangold, G. A., Fisher, A. C., & Creasy, G. W. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03275-7 · Cited by 298
Vercellini, P., Frontino, G., De Giorgi, O., Pietropaolo, G., Pasin, R., & Crosignani, P. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00794-5 · Cited by 289 · cited 2×
“COCs are used widely as initial therapy for women with chronic pelvic pain whose suspected cause is endometriosis, as these agents are generally well tolerated with less metabolic impact than danazol or GnRH analogues (Rice, 2002; Vercellini et al., 2003a).”
BackgroundSelf-citation(1987) · PubMed · Cited by 275
Self-citationTreatment of severe postmenopausal endometriosis with an aromatase inhibitor
Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00022-3 · Cited by 270
Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness
Biberoglu, K. O., & Behrman, S. J. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90478-6 · Cited by 267
Roumen, F. J. M. E., Apter, D., Mulders, T. M. T., & Dieben, T. O. M. (2001) · Human Reproduction · doi:10.1093/humrep/16.3.469 · Cited by 264
Timmer, C. J., & Mulders, T. M. T. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039030-00005 · Cited by 259
Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up
Waller, K. G., & Shaw, R. W. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55791-4 · Cited by 252
Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study
Hornstein, M. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00620-0 · Cited by 243
Telimaa, S., Puolakka, J., & Kauppila, A. (1987) · Gynecological Endocrinology · doi:10.3109/09513598709082692 · Cited by 241 · cited 3×
“In one trial (n = 59), 6 month treatment with either danazol or medroxyprogesterone acetate (MPA) significantly reduced endometriosis-associated pelvic pain, lower back pain and defecation pain compared with placebo (Telimaa et al., 1987a).”
BackgroundResultAilawadi, R. K., Jobanputra, S., Kataria, M., Gurates, B., & Bulun, S. E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.09.029 · Cited by 236
Progestins for symptomatic endometriosis: a critical analysis of the evidence
Vercellini, P., Cortesi, I., & Crosignani, P. G. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00193-3 · Cited by 232
Self-citationSeli, E. U., Berkkanoğlu, M., & Arici, A. M. (2003) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(02)00052-9 · Cited by 198
(2004) · Endometriosis in Clinical Practice · doi:10.3109/9780203319390-12 · Cited by 189
Injectable Hormone Contraception and Bone Density: Results from a Prospective Study
Scholes, D., LaCroix, A. Z., Ichikawa, L. E., Barlow, W. E., & Ott, S. M. (2002) · Epidemiology · doi:10.1097/00001648-200209000-00015 · Cited by 187
The combined contraceptive vaginal ring, NuvaRing®: an international study of user acceptability
Novák, A., de la Loge, C., Abetz, L., & van der Meulen, E. A. (2003) · Contraception · doi:10.1016/s0010-7824(02)00514-0 · Cited by 183
Crosignani, P. G., Luciano, A., Ray, A., & Bergqvist, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei290 · Cited by 179
Self-citationContraceptive efficacy and safety of DMPA-SC
Jain, J., Jakimiuk, A. J., Bode, F. R., Ross, D., & Kaunitz, A. M. (2004) · Contraception · doi:10.1016/j.contraception.2004.06.011 · Cited by 178
Jones, G. L., Kennedy, S. H., & Jenkinson, C. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.124940 · Cited by 161
Vercellini, P., De Giorgi, O., Oldani, S., Cortesi, I., Panazza, S., & Crosignani, P. G. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70152-7 · Cited by 161 · cited 18×
“In more recent randomized comparative trials of progestins in the treatment of endometriosis, both depot MPA (DMPA, 150 mg/ 3 months by IM injection) and dienogest demonstrated pain reduction comparable with that achieved with other standard medical therapies: DMPA in comparison with danazol plus COCs (Vercellini et a…”
BackgroundMethodInfluentialSelf-citationCauses and consequences of oral contraceptive noncompliance
Rosenberg, M., & Waugh, M. S. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70718-0 · Cited by 155
Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis
Hornstein, M. D., Hemmings, R., Yuzpe, A. A., & Heinrichs, W. L. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00360-9 · Cited by 155
Cosson, M., Querleu, D., Donnez, J., Madelenat, P., Konincks, P., Audebert, A., & Manhes, H. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03270-8 · Cited by 153
Endometriosis: Treatment Strategies
VALLE, R. F., & SCIARRA, J. J. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.026 · Cited by 151
A prospective, controlled study of the effects of hormonal contraception on bone mineral density
Berenson, A. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01495-8 · Cited by 151
Progestogens for endometriosis: forward to the past
Vercellini, P. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg030 · Cited by 147 · cited 6×
“Progestins also appear to offer benefits in treating patients after surgery for endometriosis , reducing the probability of pain recur - rence and lengthening the symptom - free period relative to post - surgical expectant management ( Vercellini et al .”
BackgroundInfluentialSelf-citationMuzii, L., Marana, R., Caruana, P., Catalano, G. F., Margutti, F., & Panici, P. B. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106817 · Cited by 141
Blei, F., Wilson, E. L., Mignatti, P., & Rifkin, D. B. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041550315 · Cited by 138
Lockhat, F. B. (2004) · Human Reproduction · doi:10.1093/humrep/deh004 · Cited by 135
Jain, J. K., Dutton, C., Nicosia, A., Wajszczuk, C., Bode, F. R., & Mishell, D. R. (2004) · Contraception · doi:10.1016/j.contraception.2004.01.011 · Cited by 133
Evaluation and management of women with endometriosis
Winkel, C. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00474-5 · Cited by 131
(2004) · Seminars in Reproductive Medicine · doi:10.1055/s-2004-823026 · Cited by 130
Meresman, G. F., Augé, L., Barañao, R. I., Lombardi, E., Tesone, M., & Sueldo, C. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03099-6 · Cited by 130 · cited 1×
“183 implants (Rice, 2002); COCs also have been shown to downregulate cell proliferation and increase apoptosis in the eutopic endometrium of women with endometriosis (Meresman et al., 2002).”
BackgroundTelimaa, S., & Kauppila, A. (1987) · Gynecological Endocrinology · doi:10.3109/09513598709082709 · Cited by 129
Conventional Medical Therapies for Endometriosis
RICE, V. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02795.x · Cited by 127
Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis.
Bulun, S. E., Zeitoun, K., Takayama, K., Noble, L., Michael, D., Simpson, E., Johns, A., Putman, M., & Sasano, H. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060293 · Cited by 125
Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis.
Luciano, A. A., Turksoy, R. N., & Carleo, J. (1988) · PubMed · Cited by 122
Self-citationEndometriosis: Aetiology, Pathogenesis and Treatment
Child, T. J., & Tan, S. L. (2001) · Drugs · doi:10.2165/00003495-200161120-00005 · Cited by 122
Spinal bone density in women using depot medroxyprogesterone contraception*1
CUNDY, T. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00270-1 · Cited by 117
Bone density in long term users of depot medroxyprogesterone acetate
Gbolade, B., Ellis, S., Murby, B., Randall, S., & Kirkman, R. (1998) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10211.x · Cited by 109
Pharmacokinetic overview of Ortho Evra™/Evra™
Abrams, L. S., Skee, D. M., Natarajan, J., & Wong, F. A. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03261-7 · Cited by 107
Archer, D. F., Cullins, V. E., Creasy, G. W., & Fisher, A. C. (2004) · Contraception · doi:10.1016/j.contraception.2003.10.006 · Cited by 107
Overton, C. E., Lindsay, P., Johal, B., Collins, S. A., Siddle, N., Shaw, R. W., & Barlow, D. H. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56991-x · Cited by 105
Characteristics Related to the Prevalence of Minimal or Mild Endometriosis in Infertile Women
Bérubé, S., Marcoux, S., & Maheux, R. (1998) · Epidemiology · doi:10.1097/00001648-199809000-00006 · Cited by 104
Add-back therapy in the treatment of endometriosis-associated pain
Zupi, E., Marconi, D., Sbracia, M., Zullo, F., De Vivo, B., Exacustos, C., & Sorrenti, G. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.062 · Cited by 103
Changes in quality of life after hormonal treatment of endometriosis
Bergqvist, A., & Theorell, T. (2001) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2001.800708.x · Cited by 99
Self-citationOrr‐Walker, B. J., Evans, M. C., Ames, R. W., Clearwater, J. M., Cundy, T., & Reid, I. R. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00582.x · Cited by 97
Ovarian and endometrial function during hormonal contraception
The ESHRE Capri Workshop Group (2001) · Human Reproduction · doi:10.1093/humrep/16.7.1527 · Cited by 96
Endometriosis: The Ultimate Hormonal Disease
(2003) · Seminars in Reproductive Medicine · doi:10.1055/s-2003-41319 · Cited by 94 · cited 1×
“The growth of endometriotic lesions is also estrogen dependent, with lesions becoming inactive and gradually undergoing regression during states of ovarian down-regulation, such as amenorrhoea or menopause (Bulun et al., 1999; Gurates and Bulun, 2003; Valle et al., 2003).”
BackgroundThe Gestrinone Italian Study Group (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58682-8 · Cited by 82
Marques, A., Bahamondes, L. G., Aldrighi, J. M., & Petta, C. A. (2004) · PubMed · Cited by 80
Selective Progesterone Receptor Modulators (SPRMs): A Novel Therapeutic Concept in Endometriosis
CHWALISZ, K., GARG, R., BRENNER, R. M., SCHUBERT, G., & ELGER, W. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02798.x · Cited by 77
Miller, J. D. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106846 · Cited by 67
Bone density among long-term users of medroxyprogesterone acetate as a contraceptive
Paiva, L. C., Pinto-Neto, A. M., & Faúndes, A. (1998) · Contraception · doi:10.1016/s0010-7824(98)00125-5 · Cited by 63
Parazzini, F., Cintio, E. D., Chatenoud, L., Moroni, S., Ardovino, I., Struzziero, E., Falsetti, L., Bianchi, A., Bracco, G., Pellegrini, A., et al. (2000) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(99)00131-1 · Cited by 63
Ovarian and endometrial function during hormonal contraception
Baird, D. T., Collins, J. A., Cooke, I. D., Glasier, A. F., Jacobs, H. S., Vecchia, C. L., Stock, G. J., Vercellini, P., Cohen, J., Crosignani, P. G., et al. (2001) · Human Reproduction · Cited by 61
Self-citationHenzl, M. R., & Loomba, P. K. (2003) · PubMed · Cited by 58
Regidor, P., Regidor, M., Schmidt, M., Ruwe, B., Lübben, G., Förtig, P., Kienle, E., & Schindler, A. E. (2001) · Gynecological Endocrinology · doi:10.1080/713602841 · Cited by 56
Tang, O. S., Tang, G., Yip, P. S. F., & Li, B. (2000) · Contraception · doi:10.1016/s0010-7824(00)00168-2 · Cited by 54
Cirkel, U., Ochs, H., & Schneider, H. P. G. (1995) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(94)02016-8 · Cited by 53
Current place of progestins in the treatment of endometriosis-related complaints
Schweppe, K.-W. (2001) · Gynecological Endocrinology · doi:10.1080/gye.15.s6.22.28 · Cited by 53
Perrotti, M. A., Bahamondes, L. G., Petta, C. A., & Castro, S. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01936-7 · Cited by 48
Scholes, D., LaCroix, A. Z., Ichikawa, L., Barlow, W. E., & Ott, S. M. (2004) · Contraception · doi:10.1016/j.contraception.2003.10.005 · Cited by 47
Haney, A. F., & Weinberg, J. B. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(88)80106-6 · Cited by 46
Laparoscopic Management of Patients with Endometriosis and Chronic Pelvic Pain
MILINGOS, S., PROTOPAPAS, A., DRAKAKIS, P., LIAPI, A., LOUTRADIS, D., KALLIPOLITIS, G., MILINGOS, D., & MICHALAS, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.030 · Cited by 45
Surgical management of endometriosis
Vercellini, P., Giorgi, O. D., Pisacreta, A. M., Pesole, A., Vicentini, S., & Crosignani, P. G. (2000) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.1999.0088 · Cited by 45
Self-citationFilicori, M., Flamigni, C., Cognigni, G. E., Dellai, P., Arnone, R., Falbo, A. I., & Capelli, M. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.1.8325935 · Cited by 39
Fraser, I. S., Shearman, R. P., Jansen, R. P. S., & Sutherland, P. D. (1991) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1991.tb01807.x · Cited by 38
A cost-effective approach to the management of endometriosis
Winkel, C. A. (2000) · Current Opinion in Obstetrics and Gynecology · doi:10.1097/00001703-200008000-00009 · Cited by 37
Rotondi, M., Labriola, D., Rotondi, M., Ammaturo, F. P., Amato, G., Carella, C., Izzo, A., & Panariello, S. (2002) · PubMed · Cited by 33
Olive, D. L. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200211004-00001 · Cited by 31
Self-citationPositive predictive value of clinical diagnosis of endometriosis.
Cheewadhanaraks, S., Peeyananjarassri, K., Dhanaworavibul, K., & Liabsuetrakul, T. (2004) · PubMed · Cited by 26
Endometriosis: A genetic disease
Wenzl, R. J., Kiesel, L., Huber, J. C., & Wieser, F. (2003) · Drugs of today · doi:10.1358/dot.2003.39.12.799414 · Cited by 26
Crosignani, P. G., Gastaldi, A., Lombardi, P. L., Montemagno, U., Vignali, M., Serra, G. B., & Stella, C. (1992) · PubMed · Cited by 25
Self-citationUse of estrogen antagonists and aromatase inhibitors in endometriosis.
Viganò, P., Mangioni, S., Odorizzi, M. P., Chiodini, A., Rocca, S., & Chiodo, I. (2003) · PubMed · Cited by 23
Donnez, J., Dewart, P. J., Hedon, B., Perino, A., Schindler, A. E., Blumberg, J., & Querleu, D. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.07.013 · Cited by 18
Evaluation of the Role of Laser Treatment for the Treatment of Pain in Endometriosis
Shaw, R. W. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.027 · Cited by 15
Effects of the Novel Orally Active Antiestrogen TZE-5323 on Experimental Endometriosis
Saito, T., Yoshizawa, M., Yamauchi, Y., Kinoshita, S., Fujii, T., Mieda, M., Sone, H., Yamamoto, Y., & Koizumi, N. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1297141 · Cited by 15
(1996) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1996.tb02924.x · Cited by 15
(1997) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(97)89843-8 · Cited by 14
Endometriosis-related Infertility: A Comprehensive Manual
Ferrero, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-50662-8 · Cited by 14
Merits of DMPA relative to other reversible contraceptive methods.
Nelson, A. L. (2002) · PubMed · Cited by 13
Research works printed but not linked: 19
- Berenson, 2001, Obstet Gynecol, 98, 576
- Chang, 1996, Chin Med J (Taipei), 57, 431
- Cheewadhanaraks, 2004, J Med Assoc Thai, 87, 740
- Crosignani, 1992, Clin Ther, 14, 29
- Crosignani, 2005, Hum Reprod
- Cundy, 1998, Obstet Gynecol, 92, 569
- Filicori, 1993, J Clin Endocrinol Metab, 77, 130
- Gianetto-Berrutti, 2003, Minerva Ginecol, 55, 407
- Henzl, 2003, J Reprod Med, 48, 525
- Luciano, 1988, Obstet Gynecol, 72, 323
- Marques, 2004, J Reprod Med, 49, 115
- Nelson, 2002, J Reprod Med, 47, 781
- Olive, 1987, Obstet Gynecol, 69, 412
- Regidor, 2001, Gynecol Endocrinol, 15, 202, 10.1080/gye.15.3.202.209 · doi:10.1080/gye.15.3.202.209 · Paper page
- Rotondi, 2002, Eur J Gynaecol Oncol, 23, 523
- Saito, 2003, Arzneimittelforschung/Drug Res, 53, 507
- Schlaff, Fertil Steril.
- Viganò, 2003, Curr Opin Investig Drugs, 4, 1209
- Winkel, 2003, Obstet Gynecol, 102, 397
Cited by
Dysmenorrhea and related disorders
Bernardi, M., Lazzeri, L., Perelli, F., Reis, F. M., & Petraglia, F. (2017) · F1000Research · doi:10.12688/f1000research.11682.1 · Cited by 367
Janssen, E. B., Rijkers, A. C. M., Hoppenbrouwers, K., Meuleman, C., & D'Hooghe, T. M. (2013) · Human Reproduction Update · doi:10.1093/humupd/dmt016 · Cited by 318
Reevaluating response and failure of medical treatment of endometriosis: a systematic review
Becker, C. M., Gattrell, W. T., Gude, K., & Singh, S. S. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.05.004 · Cited by 302
“Combination with add-back therapy may extend the period for which GnRH agonists can be used, although long-term safety data on this treatment regimen are limited (3).”
BackgroundHarada, T., Momoeda, M., Taketani, Y., Hoshiai, H., & Terakawa, N. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.08.051 · Cited by 289
Harada, T., Momoeda, M., Taketani, Y., Aso, T., Fukunaga, M., Hagino, H., & Terakawa, N. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.12.080 · Cited by 279
Metadata
- Authors
- Crosignani, P., Olive, D., Bergqvist, A., & Luciano, A.
- Affiliations
- University of Milan (IT)
- Karolinska Institutet (SE)
- University of Connecticut (US)
- Corresponding author
- Crosignani, PierGiorgio
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-11-09
- Volume
- 12
- Issue
- 2
- Pages
- 179-189
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2141979474
- Cited by
- 237
- References
- 94
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 5 · 2023: 7 · 2022: 2 · 2021: 8 · 2020: 13 · 2019: 9 · 2018: 11 · 2017: 17 · 2016: 10 · 2015: 16 · 2014: 17 · 2013: 15 · 2012: 14
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- endometriosis, endometriosis treatment, medical therapy, surgical treatment, combined oral contraceptives, danazol, GnRH analogues, progestins, add-back therapy, depot medroxyprogesterone acetate, fertility preservation, dysmenorrhea, chronic pelvic pain, quality of life, treatment side effects
- MeSH terms
- Contraceptives, Oral, Combined, Danazol, Endometriosis, Female, Hormones, Humans, Gonadotropin-Releasing Hormone, Progestins, Quality of Life, Receptors, Progesterone, Estrogen Receptor Modulators, Aromatase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.